- Consumer goods developer and manufacturer Jatcorp (JAT) is set to manufacture and sell immunity supplementary food
- In March 2020, Jatcorp teamed up with the University of Sydney to develop an antiviral food supplement
- This supplement works against a range of diseases such as herpes, influenza and norovirus and was recently expanded to include SARS-CoV-2, the virus that causes COVID-19
- These supplements contain bovine lactoferrin and findings have demonstrated antiviral activity against herpes and SARS-CoV-2
- Jatcorp's new products include a mixture of formulated milk powders and formulated supplementary food
- Commercial sales will begin in the second half of the year and will be sold throughout Australia, New Zealand and China
Read the Full Article on The Market Herald here
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.06M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20000 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 469780 | 1 |
View Market Depth
| Last trade - 16.21pm 18/09/2025 (20 minute delay) ? |
| JAT (ASX) Chart |
Day chart unavailable